Actividades asistenciales
METHODS AND SYSTEMS USING MACHINE LEARNING TO PROVIDE RISK OF A CHRONIC DISEASE OR CONDITION
09/07/2026 -
A device may receive physical activity data for a subject, wherein the physical activity data comprises raw acceleration data. A device may derive a plurality of metrics from the raw acceleration...
METHOD AND SYSTEM FOR MANAGING HEALTH DATA ACROSS MULTIPLE SUBSYSTEMS
09/07/2026 -
The invention relates to a computer-aided method and system for managing health data across multiple subsystems. More specifically, this disclosure relates to a system that detects, processes, and...
PHARMACEUTICAL DOSAGE FORMS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS
09/07/2026 -
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is...
INTERFACE DEVICE, ROBOTIC ARM, SURGICAL ROBOT SYSTEM, METHOD FOR MOUNTING ROBOTIC ARM, AND METHOD FOR DISMOUNTING ROBOTIC ARM
09/07/2026 -
The present application provides an interface device, a robotic arm, a surgical robot system, a method for mounting a robotic arm, and a method for dismounting a robotic arm. The interface device...
COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF RNAi
23/07/2026 -
The present disclosure provides compositions and methods related to drug responsive domain (DRD)-regulatable RNA interference (RNAi). Such compositions and methods provide for inhibitory RNA...
METHODS FOR SELECTIVELY DEGRADING PROTEINS
09/07/2026 -
The present disclosure relates to method for selectively degrading proteins in a cell. the present disclosure further relates to methods for treating a disease or disorder characterized by cyclin...
MULTI-LAYER PHARMACEUTICAL COMPOSITIONS COMPRISING DAPAGLIFLOZIN AND METFORMIN
09/07/2026 -
The present invention relates to pharmaceutical compositions in multi-layer tablet form comprising dapagliflozin or a pharmaceutically acceptable salt thereof and metformin or a pharmaceutically...
A SYNERGISTIC PROCESS TO ENHANCE THE BIOAVAILABILITY AND BIO EFFICACY OF BIOACTIVE MOLECULES
09/07/2026 -
The present invention discloses to enhance the bioavailability and bio efficacy of bioactive molecules. The process (100) comprises steps of isolating the bioactive molecules (101), high...
OXYGEN CONCENTRATOR
09/07/2026 -
The present specification relates to the field of ventilation therapy apparatuses. Provided is an oxygen concentrator. The oxygen concentrator comprises a main support, a compressor and an...
POLYMORPHIC COMPOUNDS AND USES THEREOF
23/07/2026 -
The present invention provides freebase and salt forms useful for treating various SMARCA2-mediated disorders, such as cancer, by the administration of small molecule therapeutics that act as...
COMBINATIONS COMPRISING A PARP-1 SELECTIVE INHIBITOR AND ANTI-NEOPLASTIC AGENTS FOR THE TREATMENT OF CANCER
23/07/2026 -
The present invention relates to the therapeutic combinations comprising (a) the PARP-1 selective non-trapper inhibitor Compound 1 and (b) an alkylating agent or (c) a topoisomerase inhibitor and...
PARP INHIBITOR COMBINATION THERAPY WITH DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
23/07/2026 -
Provided herein are methods of treating cancer in a subject in need thereof, the methods comprising administering to the subject a poly (ADP-ribose) polymerase (PARP) inhibitor, a deoxyuridine...
COMBINATIONS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS AND HETEROAROTINOIDS AND METHODS OF USE AS CANCER TREATMENTS
23/07/2026 -
[0000] A cancer treatment method for treating a subject in need of such therapy, the method comprising administering a therapeutically-effective amount of a heteroarotinoid compound and a Poly...
N-CYANOPYRROLIDINES WITH ACTIVITY AS INHIBITORS OF THE USP30
23/07/2026 -
The present invention provides compounds of formula (I) a tautomer thereof, or a pharmaceutically acceptable salt of said compound or tautomer, wherein: (a) X1 is CR4a and X2 is N, or (b) X1 is N...
ANTI-IL-2 ANTIBODY COMBINATIONS AND METHODS OF USE THEREOF
23/07/2026 -
Described herein are therapeutic methods for subjects having an unresectable locally advanced or metastatic cancer. The method includes administration of engineered anti-IL-2 antibodies in...
COMPOSITION COMPRISING ENDOXIFEN WITH A DEFINED AMOUNT OF IMPURITIES, ITS USE IN THERAPY AND ITS SYNTHESIS
23/07/2026 -
The present disclosure provides industrially scalable methods of making (Z)-endoxifen or a pharmaceutically acceptable salt thereof having improved safety and scalability compared to previous...
A TUMOR-SPECIFIC HLA-BOUND NEOANTIGENIC PEPTIDE ENCODED BY EWSR1::FLI1-INDUCED NEOGENES
23/07/2026 -
The present invention provides tumor-specific HLA-bound neoantigenic peptides encoded by EWSR1::FLI1-Induced neogenes, vaccinal compositions comprising such tumor-specific neoantigenic peptides,...
COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF
23/07/2026 -
The present disclosure provides, in certain embodiments, compounds chelated or covalently bound to therapeutic or diagnostic radionuclides, such as a chelated or covalently bound complexes of...
ACTIVE IMMUNIZATION FOR REDUCING OSTEOARTHRITIC, NEUROPATHIC, AND CANCER PAIN
23/07/2026 -
An immunogenic fusion protein is provided capable of conferring immunity to osteoarthritis in mammals, including canine, feline, and equine as well as methods of their use and preparation are also...
LOW-DOSE DOPAMINERGIC DRUGS TO DELAY THE PROGRESSION OF SPINOCEREBELLAR ATAXIA TYPE 3 AND ALZHEIMER'S DISEASE
23/07/2026 -
The present invention refers to dopaminergic drugs such as dopamine precursors and aromatic L-amino acid decarboxylase (AADC) inhibitors for use in a treatment to delay the progression of...
Actividades asistenciales
Agroalimentación
Automoción y nueva movilidad
Energía sostenible y eficiente
Materiales avanzados
Medio ambiente y sostenibilidad
Patrimonio natural y cultural
Procesos productivos e industria 4.0
Química y biotecnología
Salud y calidad de vida
Transformación digital



